Leukemia-associated virus immunogen, vaccine and assay
US4663436A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 24, 1984 |
| Grant date | May 5, 1987 |
| Priority date | — |
| Expiry date | Apr 24, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/13022
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a leukemia-associated virus immunogens, vaccines, and assays. The immunogens are relatively short polypeptides with peptide sequences corresponding to the antigenic determinant domains of a leukemia-associated virus envelope protein. The immunogens when introduced into a host stimulate the production of antibodies which immunoreact with the polypeptides and the leukemia-associated virus. The immunogens may be used together with other components such as adjuvants to form immunizing compositions such as vaccines. The antibodies may be used together with other components in an assay system to detect the presence of a leukemia-associated virus antigen in a body fluid sample. The antibodies can also be used in the treatment of leukemia-associated virus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.